Literature DB >> 19796532

Toll-like receptor 4 (TLR4) gene polymorphisms in Italian patients with Behçet's disease.

L Boiardi1, F Atzeni, B Casali, E Farnetti, D Nicoli, N Pipitone, M G Catanoso, I Olivieri, F Cantini, F Salvi, R La Corte, G Triolo, D Filippini, G Paolazzi, C Salvarani.   

Abstract

OBJECTIVE: To investigate potential associations between toll-like receptor 4 (TLR4) gene polymorphisms and susceptibility to, clinical features, and severity of Behçet's disease (BD).
METHODS: A total of 189 Italian patients who satisfied the International Study Group criteria for BD and 210 healthy age- and sex-matched blood donors were genotyped for two coding single nucleotide polymorphisms of TLR4 (Asp299Gly and Thr399Ile) by molecular methods. The patients were subgrouped according to the presence or absence of clinical manifestations. Severity score was calculated.
RESULTS: The distribution of allele and genotype frequencies did not differ significantly between the BD patients and the healthy controls. No significant associations were found when BD patients with and those without clinical manifestations were compared. No association between TLR4 polymorphisms and severity score was observed.
CONCLUSION: Our data suggest that the TLR4 gene polymorphisms are not associated with susceptibility to, clinical expression of, and severity of BD in Italian patients.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19796532

Source DB:  PubMed          Journal:  Clin Exp Rheumatol        ISSN: 0392-856X            Impact factor:   4.473


  10 in total

Review 1.  Pattern recognition receptors in immune disorders affecting the skin.

Authors:  Heleen D de Koning; Anna Simon; Patrick L J M Zeeuwen; Joost Schalkwijk
Journal:  J Innate Immun       Date:  2012-03-06       Impact factor: 7.349

Review 2.  Toll-like receptor polymorphisms and vasculitis susceptibility: meta-analysis and systematic review.

Authors:  Gwan Gyu Song; Sung Jae Choi; Jong Dae Ji; Young Ho Lee
Journal:  Mol Biol Rep       Date:  2012-10-14       Impact factor: 2.316

3.  Promoter -2518 single nucleotide polymorphism of monocyte chemoattractant protein-1 is associated with clinical severity in Behçet's disease.

Authors:  Seong-Kyu Kim; Won-Cheoul Jang; Young-Chang Ahn; Sang-Hyun Lee; Shin-Seok Lee; Jin-Wuk Hur
Journal:  Inflamm Res       Date:  2012-04-03       Impact factor: 4.575

4.  The Immunogenetics of Behcet's Disease.

Authors:  Mustafa Anıl Yılmaz; Ümit Türsen
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

5.  Association of TLR4 gene polymorphisms with childhood Henoch-Schönlein purpura in a Chinese population.

Authors:  Hui Xu; Guizhen Jiang; Hongqiang Shen; Wei Li; Jianhua Mao; Yanxiang Pan
Journal:  Rheumatol Int       Date:  2017-09-13       Impact factor: 2.631

6.  TLR4 polymorphisms as potential predictors of atopic dermatitis in Chinese Han children.

Authors:  Jianrong Shi; Lin He; Ran Tao; Huiwen Zheng; Wei Li; Shuangshuang Huang; Yunling Li; Shiqiang Shang
Journal:  J Clin Lab Anal       Date:  2022-03-29       Impact factor: 3.124

Review 7.  Immune Regulatory Genes Are Major Genetic Factors to Behcet Disease: Systematic Review.

Authors:  Yan Deng; Weifeng Zhu; Xiaodong Zhou
Journal:  Open Rheumatol J       Date:  2018-06-29

8.  TLR-4 and VEGF polymorphisms in chronic periaortitis.

Authors:  Fabiola Atzeni; Luigi Boiardi; Augusto Vaglio; Davide Nicoli; Enrico Farnetti; Alessandra Palmisano; Nicolò Pipitone; Davide Martorana; Gabriella Moroni; Selena Longhi; Francesco Bonatti; Carlo Buzio; Carlo Salvarani
Journal:  PLoS One       Date:  2013-05-14       Impact factor: 3.240

Review 9.  Skewed Helper T-Cell Responses to IL-12 Family Cytokines Produced by Antigen-Presenting Cells and the Genetic Background in Behcet's Disease.

Authors:  Jun Shimizu; Fumio Kaneko; Noboru Suzuki
Journal:  Genet Res Int       Date:  2013-12-30

Review 10.  Innate and Adaptive Responses to Heat Shock Proteins in Behcet's Disease.

Authors:  H Direskeneli
Journal:  Genet Res Int       Date:  2013-12-31
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.